Who Qualifies — The Core Requirements
To qualify for the prenatal acetaminophen-ASD/ADHD lawsuit, you must generally meet three criteria: (1) The mother used any acetaminophen product during pregnancy — this includes Tylenol brand and every generic or store-brand equivalent; (2) The child was born at or after 24 weeks gestation; and (3) The child has been diagnosed with autism spectrum disorder (any level), ADHD (any presentation), or both, by a licensed medical or psychological professional before age 18. There is no minimum amount of acetaminophen use specified in the research — studies have found elevated risk even with what mothers described as 'occasional' use, though prolonged use during the second and third trimesters is most strongly associated with risk. An attorney will evaluate your specific exposure history and diagnosis.
Diagnoses That Do Not Qualify
The following conditions do not qualify as primary litigation injuries because they have established genetic or chromosomal causes that are independent of prenatal chemical exposure: Down syndrome (trisomy 21), Fragile X syndrome, Rett syndrome, Angelman syndrome, Prader-Willi syndrome, Tourette syndrome (as an isolated diagnosis without ASD/ADHD), and ASD or ADHD in a child with a confirmed chromosomal abnormality explaining the diagnosis. If your child has ASD or ADHD in addition to one of these conditions, but the ASD/ADHD is not attributable to the genetic condition, an attorney should evaluate whether the neurodevelopmental diagnoses are independent compensable injuries. This is a nuanced question requiring individual assessment.
What Counts as Sufficient Exposure
Any use of acetaminophen during pregnancy may support a claim — there is no established minimum dose threshold in the litigation. Tylenol was the virtually universal recommendation for pain and fever management during pregnancy for decades (aspirin and ibuprofen are contraindicated during pregnancy), meaning the vast majority of pregnant women in the United States used acetaminophen at least occasionally. If your OB recommended Tylenol for headaches, fever, or pain at any point during your pregnancy, that recommendation is evidence of use. If you filled a prescription for acetaminophen-containing products, those pharmacy records are retrievable. If you purchased OTC acetaminophen at a pharmacy or grocery store, store loyalty card records may show the purchase.
Frequently Asked Questions
Related Pages
Tylenol Liver Damage Lawsuit
Acetaminophen — the active ingredient in Tylenol — is the leading cause of acute liver failure in the United States, responsible for approximately 56,000 emergency room visits, 26,000 hospitalizations, and nearly 500 deaths each year. Lawsuits allege that McNeil Consumer Healthcare and parent company Johnson & Johnson failed to adequately warn consumers about the narrow margin between a therapeutic dose and a potentially fatal overdose. Even doses only slightly above the recommended amount, especially when combined with alcohol use or taken across multiple acetaminophen-containing products, can cause catastrophic liver damage. If you or a loved one suffered acute liver failure, liver transplant, or death linked to acetaminophen use, you may be eligible for compensation. These liver damage claims are separate from the Tylenol autism/ADHD litigation — they involve direct injury to the person who took the medication.
Learn moreLearn moreLearn moreLearn moreLearn moreLearn moreTylenol Autism Lawsuit Lawsuit
Acetaminophen — sold under the brand name Tylenol by Kenvue (formerly Johnson & Johnson) and as dozens of store-brand generics by Walmart, CVS, Walgreens, Target, Costco, Meijer, and others — was the most commonly used pain reliever during pregnancy in the United States for decades. Starting with a landmark 2018 American Journal of Epidemiology meta-analysis of 130,000 mother-child pairs, and culminating in a 2021 consensus statement signed by 91 scientists published in Nature Reviews Endocrinology, accumulating evidence linked prolonged prenatal acetaminophen exposure to significantly elevated risks of autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD). The federal multidistrict litigation, MDL-3043 (In re Acetaminophen — ASD/ADHD Products Liability Litigation) in the Southern District of New York, was dismissed in August 2024 after Judge Denise L. Cote excluded all plaintiffs' general causation experts under the Daubert standard. Critically, the Second Circuit Court of Appeals heard oral arguments on November 17, 2025 — and two of the three judges on the panel openly questioned whether Judge Cote acted too aggressively in excluding the expert testimony. A reversal by the Second Circuit could reinstate thousands of federal cases. Separately, California state courts (Alameda County) and Illinois state courts (St. Clair, Madison, and Cook counties) have active acetaminophen-autism cases proceeding under the Frye admissibility standard, which does not apply the same gatekeeping test that closed the federal MDL. Store-brand acetaminophen users have the same legal claims as Tylenol brand users — the failure-to-warn theory applies equally to Walmart's Equate brand, CVS Health brand, Walgreens brand, Costco Kirkland brand, and all other private-label acetaminophen products.
View full case overview